ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,882, issued on Nov. 11, was assigned to ALVOTECH HF (Reykjavik, Iceland).
"Pharmaceutical formulations for adalimumab" was invented by Gudrun Bachmann (Reykjavik, Iceland) and Elin Edwald (Reykjavik, Iceland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition comprises a buffer-less aqueous formulation of adalimumab, a salt, a polyol, and a polysorbate. The formulation is suitable for injection."
The patent was filed on Feb. 16, 2022, under Application No. 17/673,149.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...